Registered Members    login
Legal and ethical issues | Literature
Organizations promoting the best practices in research
Organizations opposing xenotransplantation
Animal rights organizations opposing xenotransplantation
Bioethics sites
Catalogue of all the research activities of the genomics and biotechnology
Links to the catalogue of all the research activities of the genomics and biotechnology for health part of the life sciences, genomics and biotechnology for health programme of the sixth fp

EPI-VECTOR Consortium

It is funded by The European Commission under the Framework 6 funding programme. The project leader, Dr Dean Jackson, is a member of staff at The University of Manchester. The consortium contains a total of 9 groups from leading laboratories across Europe.
The purpose of the project is to develop episomal vectors as gene delivery systems for therapeutic application. The funding stream is through the section of life sciences, genomics and biotechnology for health, with the specific aim of designing molecular strategies to improve the precision in gene transfer for therapeutic applications.
The project is broken down into four sections: Design: genetic elements; Design: Epigenetic features; Application: Stem cell; Application: Model System.

ALLOSTEM: An Unprecedented immunology programme

AlloStem is a cutting-edge blood and marrow transplantation research programme funded by the European Commission that will run for 42 months with the participation of leading immunologists and clinical scientists forming a consortium of 29-strong partners. AlloStem is an ambitious programme dedicated to improving cancer and leukaemia therapies and is being spearheaded by Professor Alejandro Madrigal, Scientific Director of The Anthony Nolan Trust in London, UK.

RISET: Reprogramming the Immune System for Establishment of Tolerance

Transplantation dramatically improves survival of patients with established organ failure. However, as a direct consequence of immunosuppressive drugs, recipients have a significantly increased risk of both infections and malignancies. Recent scientific advances indicate that the induction of tolerance, defined as permanent acceptance of transplant in absence of continuous immunosuppression, is an achievable goal. RISET is a multinational European project financed by the European Commission within the Sixth Framework Programme, that will focus on the translation of these advances in research into clinical practice and industrial development.

EUROSTEMCELL

The European stem cell portal brings a broad spectrum of stem cell information. Supported by some of Europe’s leading stem cell scientists, EuroStemCell has specialized content for researchers, accessible resources for non-scientists and award-winning films. Plus critical analysis of the latest developments in stem cell research and space for all to have their say: a European stem cell community

GENOSTEM

Genostem represents a consortium of European leading scientists from public bodies, private institutes and private companies working together in an Integrated Project of the European Commission FP6 research funding programme. Genostem brings together experts in cellular biology, molecular biology, biomechanics, genomics, biomaterials proteomics, bioinformatics, and molecular medicine, collaborating in order to improve the therapeutic approaches for connective tissue disorders such as osteoarthritis, osteoporosis, rheumatoid arthritis, bone diseases, trauma associated pathologies… The project is coordinated by Christian Jorgensen from the French National Institute of Health and Medical Research.

OSTEOCORD

OSTEOCORD: Optimised isolation, characterisation and osteogenic induction of mesenchymal stem cells from umbilical cord blood
The aim of the OsteoCord project is to optimise the isolation and expansion of MSCs from human UCB (CB-MSCs). The differentiation capacity of CB-MSCs will be examined, with a specific focus on osteogenesis. The CB-MSCs will be characterised by genomic, proteomic and bioimpedance profiling, pre- and post-osteogenic differentiation, and compared to MSCs isolated from human bone marrow as well as embryonic stem cells.

BETACELLTHERAPY

The JDRF Center for Beta Cell Therapy in Diabetes is an international consortium that develops and implements strategies for prevention and treatment of diabetes by preserving and restoring insulin producing beta cells.
It is composed of clinical and research departments, with associated facilities and reference centers and interactions with bioindustry and society.

CRYSTAL

This website is dedicated to the dissemination of information about the European research project CRYSTAL ("CRYo-banking of Stem cells for human Therapeutic AppLication").
CRYSTAL is a research programme carried out on different type of stem cells with the aim to cryopreserve them.
The website contains general knowledge about stem cell research and related issues such as ethics in stem cell related research, and more detailed information about the specific scope and objectives of the CRYSTAL project.
A flyer containing a general project description in PDF format is available for download in the section "Publications".